-
How does MS affect the eyes?
Table of contents Eye problems are relatively common in people with multiple sclerosis and can include blurred sight, double vision, and vision loss. Multiple sclerosis treatments can help. As with the other symptoms of multiple sclerosis (MS), eye...
https://mschristian.org/index.php/blog/how-does-ms-affect-the-eyes-1 -
What to know about optic neuritis and MS
Table of contents Multiple sclerosis can damage the nerves in the eye, leading to optic neuritis. Symptoms of optic neuritis include vision problems, painful eyes, and temporary vision loss. Multiple sclerosis (MS) can cause inflammation and damage to...
https://mschristian.org/index.php/blog/what-to-know-about-optic-neuritis-and-ms -
Vision Quest - The New York Times
awakened by a hammering on the inside of my skull. It felt as if a prisoner were trying to Shawshank it out through my left eye socket. When I sat up in bed to reach for the Advil on my nightstand, I became panic-stricken. Both eyes were open, but I...
https://mschristian.org/index.php/blog/vision-quest-the-new-york-times -
New insights into protein transport could help define strategies for treating eye disease
forms of vision loss stem from a common source: impaired communication between the eye and the brain. And at the root of all eye-to-brain communication are the hundreds of proteins generated by the retina's nerve cells. Original link Many forms of...
https://mschristian.org/index.php/blog/new-insights-into-protein-transport-could-help-define-strategies-for-treating-eye-disease -
Tecfidera (dimethyl fumarate)
liver damage. Symptoms of liver damage can include: fatigue loss of appetite yellowing of your skin or the whites of your eyes Before and throughout your treatment with Tecfidera, your doctor will do blood tests to check your liver function. If your...
https://mschristian.org/index.php/blog/tecfidera-dimethyl-fumarate -
Dr Daniel Kantor Highlights MS Treatments and What Is in the Pipeline
Daniel Kantor, MD, president of Kantor Neurology. Are there any particular multiple sclerosis trials that you’re keeping an eye on? The field of MS is exciting. We’ve gone from having zero disease-modifying therapies in 1992, to our first medication in...
https://mschristian.org/index.php/blog/dr-daniel-kantor-highlights-ms-treatments-and-what-is-in-the-pipeline -
#ECTRIMS2019 - Transplanting MSCs Safe, Helps Stop Progressive MS - Multiple Sclerosis News Today
physical and neurocognitive abilities using several measures or tools, including magnetic resonance imaging (MRI) scans. An eye examination was included to detect loss of visionfrom optic nerve damage, a common symptom of MS. Effectiveness was...
https://mschristian.org/index.php/blog/ectrims2019-transplanting-mscs-safe-helps-stop-progressive-ms-multiple-sclerosis-news-today -
Study shows promise in repairing damaged myelin
covering nerve fibers in the brain and spinal cord becomes damaged, slowing or blocking electrical signals from reaching the eyes, muscles and other parts of the body. This sheath is called myelin. Although myelin can regrow through exposure to thyroid...
https://mschristian.org/index.php/blog/study-shows-promise-in-repairing-damaged-myelin -
Gilenya (fingolimod) FDA approved
profile, but some risks require consideration and monitoring * first dose usually give in doctors office * 1:200 risk of eye (macula) swelling * 1:200 risk of symptoms with slow heart rate on first dose * Need to have had chickenpox or vaccine at least...
https://mschristian.org/index.php/articles/ms-medications/21-gilenya-fingolimod-fda-approved
Follow Us on Twitter
